Spread the word. Share the Gastric Cancer Foundation Newsletter.
Join Us for a Special Evening!

Celebrate our first decade of progress and support the foundation's determined work to find a cure.
Saturday, November 16th
Peninsula Golf & Country Club
San Mateo, California

2019 'Champions of Hope' Honorees:
Diane & Ron Weintraub | Mohamad El-Zaatari, PhD | Hans Rueffert
Music by Gold Standard | Live Event Painting by Heidi Schwartz | Cork Pull to Win Fine Wines | Mirmir Photobooth | Live Auction | And More!
Visit gastriccancer.org/cfh2019 for additional information and to purchase tickets.
Inaugural Research Scholar Charts Progress on Three Research Efforts
Ever since  Mohamad El-Zaatari, Ph.D. , research assistant professor at the University of Michigan,  received the first Gastric Cancer Foundation-American Gastroenterology Association research scholar grant in 2014 , he has made great progress on the three research projects he was able to jumpstart with the three-year $270,000 award.

The grant was an important stepping stone to a half-million-dollar award from the U.S. Department of Defense that El-Zaatari received in 2017. Building on research he started with the GCF-AGA funding, El-Zaatari is now studying how precancerous lesions develop in the stomach—and how they can be treated.

“Many gastric cancers start off with immune cells attacking our own ‘self’ cells” El-Zaatari explains. This “autoimmune” process by B cells had not been previously considered to play a part in gastric cancer, and the exact role of those cells in this context is still unknown.

El-Zaatari performed studies in mice that lack B cells and was able to identify markers of precancerous changes in the stomach, he says. “Now we are investigating this further, so we can understand the exact role of B cells, because they clearly play a role.”
New Episode: A Wheat-Free Pasta Salad
This month, board member and "Chef without a Stomach,"  Hans Rueffert  is back with a new video from the Gesundheit Kitchen. His fresh and colorful salad uses his favorite red lentil pasta. It is simple and delicious - and packed with a whopping 13 grams of plant-based protein! And remember that roasted carrot recipe from episode 13 ? Why not add those for even more color and flavor! Find more episodes at the Gesundheit Kitchen on gastriccancer.org.
Research Roundup
In a large clinical trial that included patients with gastric cancer, a blood test from Guardant Health was as effective as biopsy at finding the biomarker MSI, which predicts a strong response to immunotherapy treatments.

A combination of the immunotherapy drug Keytruda with the VEGFR-2 inhibitor Cyramza was well tolerated by gastric cancer patients in a small trial and 57% of patients saw their tumors shrink.

In a trial of the investigational PD-1 antibody toripalimab combined with chemotherapy, gastric cancer patients showed a 67% response rate and an 89% disease-control rate. Patients with a high tumor mutational burden showed superior overall survival rates.
Special Thanks to Our
National Sustaining Sponsors
We are honored to welcome Astellas as our newest national sponsor.